AI Verdict
JAZZ has stronger fundamentals based on our AI analysis.
JAZZ vs JAGU Fundamental Comparison
| Metric | JAZZ | JAGU |
|---|---|---|
| Revenue | $4.3B | N/A |
| Net Income | $-356.1M | $-2.3M |
| Net Margin | -8.3% | N/A |
| ROE | -8.2% | -39.5% |
| ROA | -3.1% | -27.7% |
| Current Ratio | 1.86x | 0.19x |
| Debt/Equity | 1.24x | 0.00x |
| EPS | $-5.84 | $-0.26 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
JAZZ vs JAGU: Frequently Asked Questions
Is JAZZ or JAGU a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), JAZZ has stronger fundamentals. JAZZ is rated SELL (78% confidence) while JAGU is rated STRONG SELL (92% confidence). This is not investment advice.
How does JAZZ compare to JAGU fundamentally?
Jazz Pharmaceuticals plc has ROE of -8.2% vs Jaguar Uranium Corp.'s -39.5%. Net margins are -8.3% vs N/A respectively.
Which stock pays higher dividends, JAZZ or JAGU?
JAZZ has a dividend yield of N/A or no dividend while JAGU has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in JAZZ or JAGU for long term?
For long-term investing, consider that JAZZ has SELL rating with 78% confidence, while JAGU has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about JAZZ vs JAGU?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For JAZZ vs JAGU, the AI consensus favors JAZZ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.